CL2008003133A1 - Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. - Google Patents

Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa.

Info

Publication number
CL2008003133A1
CL2008003133A1 CL2008003133A CL2008003133A CL2008003133A1 CL 2008003133 A1 CL2008003133 A1 CL 2008003133A1 CL 2008003133 A CL2008003133 A CL 2008003133A CL 2008003133 A CL2008003133 A CL 2008003133A CL 2008003133 A1 CL2008003133 A1 CL 2008003133A1
Authority
CL
Chile
Prior art keywords
drug
alzheimer
patients
preparation
treatment
Prior art date
Application number
CL2008003133A
Other languages
English (en)
Inventor
Roura Victor Grifols
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of CL2008003133A1 publication Critical patent/CL2008003133A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

USO DE ALBÚMINA HUMANA PARA LA PREPARACIÓN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE DESÓRDENES COGNITIVOS EN PACIENTES CON ALZHEIMER SIN DEPENDENCIA DEL CONTENIDO DE AB EN SANGRE DEL PACIENTE DONDE EL MEDICAMENTO SE ENCUENTRA EN FORMA DE SOLUCIÓN PARA RECAMBIO PLASMÁTICO Y/O PERFUSIÓN INTRAVENOSA EN QUE LA ALBÚMINA ESTÁ INICIALINENTE A UNA CONCENTRACIÓN COMPRENDIDA ENTRE EL 4% (P/V) Y 25% (P/V).        
CL2008003133A 2007-10-26 2008-10-23 Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. CL2008003133A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200702831A ES2332846B1 (es) 2007-10-26 2007-10-26 Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.

Publications (1)

Publication Number Publication Date
CL2008003133A1 true CL2008003133A1 (es) 2009-08-07

Family

ID=40583637

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003133A CL2008003133A1 (es) 2007-10-26 2008-10-23 Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa.

Country Status (17)

Country Link
US (1) US7851446B2 (es)
EP (1) EP2111868B1 (es)
JP (1) JP5437619B2 (es)
CN (1) CN101417123B (es)
AR (1) AR068901A1 (es)
AU (1) AU2008233025B8 (es)
BR (1) BRPI0804623B8 (es)
CA (1) CA2641830C (es)
CL (1) CL2008003133A1 (es)
ES (2) ES2332846B1 (es)
HK (1) HK1126689A1 (es)
MX (1) MX2008013635A (es)
NZ (1) NZ572131A (es)
PL (1) PL2111868T3 (es)
PT (1) PT2111868E (es)
RU (1) RU2414925C2 (es)
UY (1) UY31418A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2802628C2 (ru) * 2018-10-25 2023-08-30 Грифольс Уорлдуайд Оперейшнс Лимитед Использование плазмафереза малого объема для лечения болезни альцгеймера на ранних и средних стадиях

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5843345B2 (ja) 2010-07-08 2016-01-13 旭化成メディカル株式会社 β−アミロイド除去システム
PL3484502T3 (pl) * 2016-08-18 2022-01-31 Alkahest, Inc. Frakcje osocza krwi jako terapia związanych ze starzeniem zaburzeń funkcji poznawczych
EA039316B1 (ru) * 2016-10-24 2022-01-12 Алкахест, Инк. Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением
DK3615057T3 (da) * 2017-04-26 2024-01-02 Alkahest Inc Doseringsskema til behandling af kognitive svækkelser med blodplasmaprodukter
US11040068B2 (en) 2017-04-26 2021-06-22 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
EP4374921A3 (en) * 2018-07-20 2024-06-19 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
EP3643319A1 (en) * 2018-10-25 2020-04-29 Grifols Worldwide Operations Limited Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages
JP7504090B2 (ja) 2018-10-26 2024-06-21 アルカヘスト,インコーポレイテッド 疼痛、創傷治癒及び術後回復の改善のための血漿及び血漿画分の使用
AU2021372848A1 (en) * 2020-10-30 2023-06-22 Shenzhen Protgen Ltd. Use of human serum albumin in treatment of diseases
WO2022229705A1 (es) * 2021-04-30 2022-11-03 Grifols Worldwide Operations Limited Uso de recambio plasmático terapéutico y recambio plasmático de bajo volumen para el tratamiento de un deterioro cognitivo

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612137A1 (de) 1986-04-10 1987-10-15 Biotest Pharma Gmbh Steriles plasmaaustauschmittel
US5112298A (en) 1990-06-25 1992-05-12 Baxter International Inc. Apheresis method and device
US5178603A (en) 1990-07-24 1993-01-12 Baxter International, Inc. Blood extraction and reinfusion flow control system and method
US6627151B1 (en) * 1997-06-13 2003-09-30 Helmut Borberg Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion
ATE312354T1 (de) 2000-05-23 2005-12-15 Univ Southern California Diagnose von alzheimerkrankheit unter verwendung von ldl-rezeptor-protein-1
EP1370240A4 (en) * 2001-03-02 2004-09-22 Neuron Therapeutics Inc NEUROPROTECTOR FORMULATIONS AND METHOD
WO2003051374A2 (en) 2001-12-17 2003-06-26 New York State Office Of Mental Health SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
EP2210892A3 (en) 2002-10-04 2010-10-27 Prana Biotechnology Limited Neurologically-active compounds
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
UA80469C2 (en) 2003-02-13 2007-09-25 Octapharma Ag Method for the production of albumin
AU2004311577A1 (en) 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
AT413336B (de) * 2003-09-12 2006-02-15 Mattner Frank Dr Apherese-vorrichtung
US20050182044A1 (en) 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
US7436304B1 (en) 2005-07-19 2008-10-14 Visible Assets, Inc Evidence tracking

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2802628C2 (ru) * 2018-10-25 2023-08-30 Грифольс Уорлдуайд Оперейшнс Лимитед Использование плазмафереза малого объема для лечения болезни альцгеймера на ранних и средних стадиях

Also Published As

Publication number Publication date
EP2111868A1 (en) 2009-10-28
HK1126689A1 (en) 2009-09-11
BRPI0804623A2 (pt) 2009-06-30
BRPI0804623B8 (pt) 2021-05-25
RU2008141076A (ru) 2010-04-27
JP2009108059A (ja) 2009-05-21
JP5437619B2 (ja) 2014-03-12
NZ572131A (en) 2010-06-25
PT2111868E (pt) 2013-10-17
US7851446B2 (en) 2010-12-14
CN101417123A (zh) 2009-04-29
BRPI0804623B1 (pt) 2020-02-11
CA2641830A1 (en) 2009-04-26
CN101417123B (zh) 2012-06-27
MX2008013635A (es) 2009-05-11
CA2641830C (en) 2013-07-16
UY31418A1 (es) 2009-05-29
US20090111740A1 (en) 2009-04-30
AR068901A1 (es) 2009-12-16
EP2111868B1 (en) 2013-08-21
AU2008233025B2 (en) 2013-06-27
PL2111868T3 (pl) 2014-01-31
ES2428698T3 (es) 2013-11-08
RU2414925C2 (ru) 2011-03-27
ES2332846A1 (es) 2010-02-12
AU2008233025B8 (en) 2013-07-25
ES2332846B1 (es) 2010-07-08
AU2008233025A1 (en) 2009-05-14

Similar Documents

Publication Publication Date Title
CL2008003133A1 (es) Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa.
AR084816A1 (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
AR111572A2 (es) Formas farmacéuticas que contienen vardenafilo
TR201818927T4 (tr) Kataterlerde İyileştirme
WO2007108987A3 (en) Infusion device pump
AR099078A2 (es) Un medicamento que comprende acetato de glatiramer
ECSP056076A (es) Sistema de suministro para droga y terapia celular
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
BR0317450A (pt) Fluidos de diálise biocompatìveis contendo icodextrinas
AR086356A1 (es) Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2
BRPI0411032A (pt) composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica
TW200628182A (en) Injection device for administering a medication liquid
JP2013541583A5 (es)
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
ECSP077843A (es) Tratamiento o prevención del prurito
CY1116171T1 (el) Χρηση ακετυλο-l-καρνιτινης για την παρασκευη φαρμακου για τη θεραπευτικη αγωγη του νευροπαθητικου πονου σε διαβητικους ασθενεις
MY174442A (en) Treating critically ill patients with intravenous ibuprofen
AR047154A1 (es) Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
CN201441679U (zh) 走动式输液架
Club et al. Autism Spectrum Disorders
CN202314371U (zh) 输液避光瓶套
JP1781851S (ja) 薬物供給システム
Kaufman Benzocaine misuse: Methaemoglobinaemia following application of benzocaine in large amounts without a prescription multiple times in a day: case report
TWD203321S (zh) 輸液用泵浦之部分
AR063206A1 (es) Tratamiento del dolor